SCHEMBL1015608

SCHEMBL1015608

CCN(CC=CC(=O)N1CCc2c(sc3ncnc(Nc4ccc(F)c(Cl)c4)c23)C1)C1CCCCC1

nearest known ligand 0.72

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
EGFR P00533 18/20 0.72
FGFR1 P11362 1/20 0.52
CCNA2 P20248 1/20 0.51
CDK2 P24941 1/20 0.51
CCNA1 P78396 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1015606 1.00 EGFR (0.72) EGFRFGFR1CCNA2CDK2CCNA1
SCHEMBL1013295 0.94 EGFR (0.65) EGFR
SCHEMBL1013292 0.94 EGFR (0.65) EGFR
SCHEMBL1015735 0.92 EGFR (0.73) EGFRFGFR1
SCHEMBL1015734 0.92 EGFR (0.73) EGFRFGFR1
SCHEMBL1015709 0.89 EGFR (0.83) EGFR
SCHEMBL1015710 0.89 EGFR (0.83) EGFR
SCHEMBL1017385 0.89 EGFR (0.78) EGFR
SCHEMBL1017383 0.89 EGFR (0.78) EGFR
SCHEMBL1016643 0.88 EGFR (0.87) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2001890-B1 TETRAHYDROPYRIDOTHIENOPYRIMIDINE COMPOUNDS AND USE FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS BAYER SCHERING PHARMA AG (DE) 2011-01-12 EP disclosed